recombinant human IL-15
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human IL-15, covering 2021-12-14 to 2021-12-14. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome [Phase 1]